Pregaver 25 mg (Capsule)

Unit Price: ৳ 10.00 (3 x 10: ৳ 300.00)
Strip Price: ৳ 100.00

Medicine Details

Category Details
Generic Pregabalin
Company Veritas pharmaceuticals ltd
Also available as
Pregaver 50 mg capsule Pregaver 75 mg capsule

Title

  • Pregaver 25 mg Capsule

Category

  • Medicine
  • Neurological Disorders

Indications

  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury

Pharmacology

  • Structural derivative of inhibitory neurotransmitter gamma-aminobutyric acid (GABA)
  • Binds with high affinity to the alpha2-delta site in central nervous system tissues

Dosage

  • Maximum recommended dose of 100 mg three times a day for diabetic peripheral neuropathy
  • Recommended dose of 75 to 150 mg two times a day for postherpetic neuralgia
  • Recommended dose of 300 to 450 mg/day for fibromyalgia

Administration

  • Oral route
  • Should be swallowed whole
  • Should not be split, crushed or chewed

Drug Interaction

  • Unlikely to be involved in significant pharmacokinetic drug interactions

Contraindications

  • Hypersensitivity to Pregabalin or any of its components

Side Effects

  • Dizziness
  • Somnolence
  • Dry mouth
  • Edema
  • Blurred vision
  • Weight gain
  • Difficulty with concentration/attention

Pregnancy & Lactation

  • Potential risk to a fetus
  • Breastfeeding not recommended

Precautions & Warnings

  • Angioedema
  • Discontinuation in case of hypersensitivity reactions
  • Increased risk of suicidal thoughts or behavior
  • Respiratory depression may occur
  • May cause dizziness and impair ability to drive or operate machinery

Use in Special Populations

  • Safety and effectiveness not established in pediatric patients for certain conditions
  • Safety and effectiveness not established for pediatric patients below the age of 1 month for adjunctive therapy for partial onset seizures

Overdose Effects

  • Reduced consciousness
  • Depression/anxiety
  • Agitation and restlessness
  • Seizures and heart block reported
  • No specific antidote

Therapeutic Class

  • Adjunct anti-epileptic drugs
  • Primary anti-epileptic drugs

Storage Conditions

  • Keep in a cool & dry place (below 30°C)
  • Protected from light & moisture
  • Keep out of the reach of children

Chemical Structure

  • Molecular Formula: C8H17NO2
  • Chemical Structure Image URL: [URL]

Common Questions

  • What is Pregaver 25 mg Capsule?
  • How long do I need to use Pregaver 25 mg Capsule before I see improvement in my condition?
  • At what frequency do I need to use Pregaver 25 mg Capsule?
  • Storage and disposal instructions
  • Difference in the working of Pregaver 25 mg Capsule for different diseases
  • Duration of treatment
  • Necessity of continuing treatment even if feeling fine
  • Possibility of taking Diazepam and Pregaver 25 mg Capsule together
  • Possibility of weight gain as a side effect
  • Quick Tips

Pediatric Uses

  • Safety and effectiveness not established in pediatric patients for certain conditions
  • Safety and effectiveness not established for pediatric patients below the age of 1 month for adjunctive therapy for partial onset seizures

Interaction

  • Drug interaction with medication: Unlikely to be involved in significant pharmacokinetic drug interactions
  • Drug interaction with food and others: Not applicable

Contradictions

  • Pregabalin is contraindicated in patients with known hypersensitivity to Pregabalin or any of its components

Side Effects

  • Most common side effects in adults are dizziness, somnolence, dry mouth
  • Weight gain and thinking abnormal (primarily difficulty with concentration/attention)
  • Most common side effects in pediatric patients for the treatment of partial onset seizures are increased weight and increased appetite

Pregnancy Lactation

  • No adequate and well-controlled studies with pregabalin in pregnant women
  • Small amounts of pregabalin detected in the milk of lactating women
  • Breastfeeding not recommended during treatment with pregabalin

Special Populations

  • Safety and effectiveness in pediatric patients have not been established for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, neuropathic pain associated with spinal cord injury and fibromyalgia
  • Masafety and effectiveness in pediatric patients below the age of 1 month have not been established

Overdose

  • In case of overdose with Pregaver, reduced consciousness, depression/anxiety, agitation and restlessness
  • Seizures and heart block have also been reported
  • No specific antidote

Chemical Structure

  • Molecular Formula : C8H17NO2
  • Chemical Structure : URL

Frequently Asked Questions

  • What is Pregaver 25 mg Capsule?
  • Duration of usage for improvement
  • Frequency of usage
  • Storage and disposal instructions
  • Variations in efficacy for different conditions
  • Duration of usage
  • Continuous usage even if feeling fine
  • Usage with Diazepam
  • Possibility of weight gain
  • Quick Tips

Related Brands